Company intelligence / Profile preview

Deeptope

Orsay, Île-de-France, Francedeeptope.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Deeptope offers high-throughput functional testing services to accelerate the development of therapeutic antibodies and proteins. Its proprietary platform enables rapid epitope/paratope mapping and lead optimization using deep mutational scanning technologies. The company does not have its own clinical pipeline but supports biotech/pharma partners in early-stage R&D.

Therapeutic areas: Other
Modalities: AntibodyProtein (including cytokines, Fc-fusion proteins, protein scaffolds)Antibody-drug conjugateFragments (antibody fragments)Multi-, bispecific antibodiesRecombinant protein (implied by engineering and optimization services)
Industry: Drug Discovery Services

Partnerships

No major partnerships publicly disclosed; collaborates with biotech/pharma clients on service/co-development basis.

Beyond the preview

Go deeper on Deeptope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deeptope.

Explore the full profile